EDITORIAL SECTIONS
RESEARCH & DEVELOPMENT
Adopting the Power of AI to Drug Development Projects
A tremendous amount of documentation is created throughout the clinical trial lifecycle
CLINICAL TRIALS
Real-world Evidence
Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA
MANUFACTURING
Just in Time Manufacturing Creating more sustainable supply chains
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Information Technology
Challenges and Advantages of Using Artificial Intelligence in Pharma
Many advanced largescale AI initiatives still need to be proved successful in Pharma
KNOWLEDGE BANK
Interviews
Porton Pharma Solutions and Codexis Launch Global Partnership
PARTNERSHIP
Codexis Inc and Porton Pharma Solutions Ltd announce a strategic collaboration to deploy Codexis worldleading biocatalyst technology within Portons global custom intermediate and active pharmaceutical ingredients API development and manufacturing business The partnership will accelerate the creation and commercialization of new lowcost sustainable manufacturing processes exploiting the benefits of...
Articles
QSAR - Changing the Landscape of Antidiabetic Drug Discovery
QSAR techniques are contributing in a major way to drug design by improving the potency efficacy and selectivity of the lead compounds in drug design This is also true for drug design for diabetes where techniques like virtual screening and DQSAR are helping scientists design drugs with reduced side effects and increased efficacy and potency
Research Insights
Progress And Perspectives On Targeting Nanoparticles For Brain Drug Delivery
Abstract Due to the ability of the bloodbrain barrier BBB to prevent the entry of drugs into the brain it is a challenge to treat central nervous system disorders pharmacologically The development of nanotechnology provides potential to overcome this problem In this review the barriers to braintargeted drug delivery are reviewed including the BBB
Case Studies
Labile Biologics - Stable Aqueous Formulation of Recombinant Factor VIII
Challenge All marketed Factor VIII products are lyophilised preparations produced by either recombinant technology or purified from pooled plasma The preparations are typically stabilised by addition of sugars Administration of the lyophilised product is a very complex procedure involving a number
Techno Trends
High speed production of new antibiotics that could treat MRSA and drug-resistant TB
Scientists at the University of Bristol have found a faster and cheaper way to produce new antibiotics to tackle drugresistant superbugs There was a per cent increase in production when the genes involved in the pleuromutilin production were expressed in a different type of fungus by the research team This is considered to b
White Papers
Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches
In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS
TOP ARTICLES
Nanotechnology Strategies for Age –Related Macular Degeneration
Aira Sarkar is pursuing B. Tech (Pharmaceutical Chemistry and Technology) in Department of Pharmaceutical Science and Technology, Institute of Chemical Technology (ICT).
Sathish Dyawanapelly is working as an Assistant Professor in Department of Pharmaceutical Science and Technology, Institute of Chemical Technology (ICT).
Approach for Producing Pharmaceuticals in Layer By Layer Fashion: Additive Manufacturing
Lakshmi usha Ayalasomayajula is an Assistant Professor in the Department of Pharmaceutical Technology at M.R. College of Pharmacy, India with 9 years of teaching and research experience. She has published 30 papers in international and national journals and has presented 20 papers in various conferences as author and co-author.
Earle Radha Rani is working as assistant professor in department of pharmaceutical technology, Maharajah’s College of Pharmacy, Andhra Pradesh, India. She has 7 years of teaching experience and has published over 30 research and review articles in several reputed national and international journals. Her areas of interest include novel drug delivery systems.
AVS Ksheera Bhavani is working as assistant professor in department of Pharmaceutical Biotechnology, Maharajah’s College of Pharmacy, Andhra Pradesh, India. She has about 10 years of teaching experience and has published over 10 research and review articles in several reputed national and international journals. Her areas of interest include novel drug delivery systems.
kishore pathivada ,an under graduate from Maharajah's college of pharmacy, Vizianagaram, during the year, 2017-21. I Qualified GPAT-2021 with AIR 705 and I also got qualified in NIPER JEE-2021 with AIR 62.Currently Iam pursuing my master's degree in Dept. of pharmaceutical Analysis at NIPER Mohali, Punjab which is one of the top most reputed colleges in INDIA in the field of Pharmaceutical Sciences and Research.
Probiotics as live Biomolecules to Manage Sleep Disorders
Sumel Ashique, Assistant Professor at Bharat Technology, is an accomplished pharmaceutical scientist with 150+ publications, 5 patents, and expertise in drug delivery and nanotechnology. He serves as a reviewer and guest editor for reputed journals and is currently pursuing a Ph.D. at Lovely Professional University, Punjab.
Mohini Mondal, Assistant Professor at Bharat Technology, is a dedicated pharmaceutics academic and researcher. With an M. Pharm and ongoing Ph.D., she specializes in drug delivery systems and holds an IP for an innovative ocular gel. Her work bridges teaching and research, shaping future pharmaceutical professionals.
Design of Self-antibacterial and Biocompatible Titanium Surfaces for Biomedical Applications
Lalit M Pandey is an Associate Professor at the Department of Biosciences and Bioengineering, IIT Guwahati. His main research interests include biointerfaces and biomaterials, biochemical engineering, and environmental biotechnology. He has published over hundred research articles in international journals and serves on the editorial board of six international journals. He is serving as Associate Editor in Frontiers in Bioengineering and Biotechnology. He has co-edited three books. He is a life member of the International Association of Engineers (IAENG), the National Academy of Sciences (NASI), the Indian Institute of Chemical Engineers (IIChE), the Biotech Research Society, India (BRSI), and Nano and Molecular Society (India) and serves as a reviewer for several peer-reviewed journals.
Data-Enriched Edible Pharmaceuticals (DEEP) as Patient-Tailored Drug Products
Natalja Genina, Associate professor at University of Copenhagen (UCPH), Denmark. Her research interest include fabrication of advanced drug delivery systems and their integration into digital health. Dr. Genina has a remarkable publication record in her research field.
Professor, UCPH
Associate Professor, UCPH
Sofia Kälvemark Sporrong, Professor at Uppsala University, Sweden. Expert in social pharmacy. Kälvemark Sporrong is a social scientist doing research within the area of pharmaceuticals. Her research interests include the patient perspective on drug use, pharmaceutical policy and professional ethics for health care staff.
press releasesRead more...
Agilent and Singapore’s NATi Partner to Advance Lipid-Conjugated Oligonucleotide Research
Agilent Technologies Inc today announced a twoyear research collaboration agreement with Singapores Nucleic Acid Therapeutics Initiative NATi hosted by Agency for Science Technology and Research ASTAR to accelerate research
Samsung Bioepis Launches Ustekinumab Biosimilar, Marking Its First Product Launch in Japan
Samsung Bioepis Co Ltd today announced the launch of Ustekinumab BS mg Syringe for SC Injection NIPRO a biosimilar referencing Stelara ustekinumab marking its first product launch in Japan under partnership
QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA
QIAGEN announced at the BIOIT World Conference Expo in Boston that the QIAGEN Digital Insights bioinformatics business and its curated knowledge bases and bioinformatics expertise will be integrating NVIDIA
Incyte and Edison Scientific Announce Strategic Collaboration to Employ the Kosmos AI Platform for Research and Development
Incyte NasdaqINCY and Edison Scientific today announced a strategic collaboration to employ Kosmos Edisons AI scientist for Incytes discovery and development work
Amplexd Therapeutics Initiates Phase 2 Clinical Trial of Investigational EGCg-Based HPV Therapy
Amplexd Therapeutics Inc Amplexd a USbased clinicalstage biotechnology company focused on womens health and underserved therapeutic areas today announced authorization from the Hong Kong Department
Bridging Global Markets: Cathay Cargo Redefines Cold Chain Excellence via Hong Kong’s Strategic Nexus
In the rapidly evolving logistics landscape of precision and speed define the ultimate prerequisites for highvalue essentials Leveraging Hong Kongs unparalleled geographical superpower
EventsRead more...
20 - 21
May 2026Pharmacovigilance Europe 2026
London, UK
20 - 21
May 2026Pharma Partnering EU Summit 2026
Pharma Partnering Summit
Basel Marriott Hotel, Switzerland
20 - 22
May 2026PHARMA EURASIA 2026
Pharma & Med Tech Park, Tashkent, Uzbekistan
21 - 22
May 2026Liver Diseases & Hepatology 2026
Paris, France
27 - 28
May 2026Digi-Tech Pharma & AI Conference
London, United Kingdom
27 - 28
May 2026Global Clinical Trials Connect 2026
London, United Kingdom
27 - 28
May 2026UK Biotech Day
Radisson Hotel & Conference Centre London Heathrow, UK
27 - 28
May 2026Future Labs Live 2026
Congress Center, Basel, Switzerland
LATEST NEWSRead more...
Exelixis and Merck Collaborate on Phase 3 Trial for Colorectal Cancer Treatment
Exelixis has announced a clinical development collaboration with Merck for the Phase STELLAR pivotal trial in patients with colorectal cancer CRC
AstraZeneca and Daiichi Sankyo Expand ENHERTU Use in Early HER2-Positive Breast Cancer in the US
AstraZeneca and Daiichi Sankyo have received approval from the US Food and Drug Administration for the use of Enhertu trastuzumab deruxtecan in both neoadjuvant and adjuvant treatment settings for patients with HERpositive early breast cancer
Regeneron and Parabilis Partner to Develop Antibody-Helicon Conjugates Across Multiple Therapeutic Areas
Regeneron Pharmaceuticals has announced a strategic research collaboration with Parabilis Medicines to discover and develop therapeutic candidates using Parabilis Helicon peptide platform
Elabscience Launches PolyHRP-Streptavidin Conjugate for ELISA Testing
Elabscience has launched a selfdeveloped PolyHRPStreptavidin conjugate designed to improve the sensitivity of enzymelinked immunosorbent assay ELISA testing for lowabundance biomarker detection
Erasca Enters into Collaboration with Merck to Evaluate ERAS-0015 with KEYTRUDA in RAS-Mutant Solid Tumours
Erasca has entered into a clinical trial collaboration and supply agreement with Merck to evaluate ERAS in combination with KEYTRUDA for patients with RASmutant solid tumours
Hengrui Pharma Enters into Collaboration with Bristol Myers Squibb to Advance Innovative Therapies
Hengrui Pharma and Bristol Myers Squibb have entered into global strategic collaboration and licensing agreements to develop a portfolio of earlystage programmes across oncology haematology and immunology